)
A newly approved biotech project in Boston's Seaport District, which includes a new mass transit stop, underscores continuing growth of the neighborhood’s life sciences sector, as well as the development of one of its last available sites.
Seaport Circle, a 1.9-acre development by Lincoln Property Co., received the green light from the Boston Planning & Development Agency. Set to include 650K SF of labs and offices, as well as a stop on the Silver Line and a standalone 15K SF training and workforce development center, the 13-story tower will also include retail space.
The development will also feature an urban terrace, and the training center, to be called the Pavilion, will be open and available for public events.
The Seaport, a former industrial hub, saw development and conversion of life sciences spaces take off during the pandemic, including forthcoming homes for Ginkgo Bioworks and Eli Lilly’s $700M mRNA research center. It is the largest life sciences submarket in Boston, boasting 2.4M SF of inventory and vacancy at 0.8% this spring, per Colliers.
)
)
)
)
)
)
)
)
)
)
)
)